In an ongoing and open collaboration between iNovacia AB, GE Healthcare, Sweden and scientists at the Department of Medical Biochemistry and Biophysics (MBB) at Karolinska Institutet, the surfaceplasmon resonance and nuclear magnetic resonance techniques have been cross-validated as fragment screening techniques.

Full press release